PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $117.0M | $38.5M |
| FY2015 | — | $206.0M | $31.6M |
| FY2016 | — | $209.8M | $194.5M |
| FY2017 | $48.5M | $53.3M | $81.7M |
| FY2018 | $151.9M | $34.3M | $108.4M |
| FY2019 | $95.0M | $17.5M | $60.0M |
| FY2020 | $84.0M | $-6.0M | $85.3M |
| FY2021 | $97.1M | $-2.4M | $63.1M |
| FY2022 | $98.3M | $21.6M | $76.2M |
| FY2023 | $65.7M | $53.4M | $84.6M |